U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07191548) titled 'An International, Multi-centre, Registry-based, Phase II Study of the Treatment of LIVER METastases From Colorectal Cancer by IRreversible Electroporation.' on Sept. 23.

Brief Summary: Procedural data will be recorded from patients with liver metastases from colorectal cancer who have received at least one course of systemic chemotherapy and who have been assessed by an appropriately constituted MDT (or equivalent) as appropriate to receive irreversible electroporation.

Study Start Date: Feb., 2026

Study Type: INTERVENTIONAL

Condition: Colorectal Adenocarcinoma Metastatic in the Liver Liver Ablation Liver Cancer, Adult

Interve...